We investigated the function of BASP1 in metastatic lung cancer cells, focusing on the interaction between EGFR and BASP1, and searched for potential drugs to target the BASP1-EGFR axis to overcome TKI resistance in lung cancer. The gene discussed is EGFR; the disease is lung cancer.